Oral tolerance inhibits pulmonary eosinophilia in a cockroach allergen induced model of asthma: A randomized laboratory study

Respiratory Research

Volumn 11, Issue , 2010, Pages

  Vaickus, Louis J ^a   Bouchard, Jacqueline ^a   Kim, Jiyoun ^a   Natarajan, Sudha ^a   Remick, Daniel G ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; CHEMOTACTIC FACTOR; COCKROACH ALLERGEN; EOSINOPHIL PEROXIDASE; EOTAXIN; EOTAXIN 2; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 4; INTERLEUKIN 5; MACROPHAGE INFLAMMATORY PROTEIN 2; OVALBUMIN; RANTES; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

AIRWAY RESISTANCE; ALLERGIC ASTHMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFICIAL VENTILATION; BRONCHUS HYPERREACTIVITY; COCKROACH; CONTROLLED STUDY; DESENSITIZATION; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL COUNT; EXPIRATORY FLOW; FEMALE; IMMUNOLOGICAL TOLERANCE; INFLAMMATORY CELL; INSPIRATORY CAPACITY; LOEFFLER PNEUMONIA; LUNG HOMOGENATE; LUNG LAVAGE; LUNG MINUTE VOLUME; MICROSCOPY; MOUSE; NONHUMAN; PLETHYSMOGRAPHY; RESPIRATORY TRACT PARAMETERS; SENSITIZATION; TH2 CELL; ANIMAL; ASTHMA; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DISEASE MODEL; DRUG TOLERANCE; HUMAN; IMMUNOLOGY; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL;

ALLERGENS; ANIMALS; ASTHMA; COCKROACHES; DISEASE MODELS, ANIMAL; DRUG TOLERANCE; FEMALE; HUMANS; MICE; PULMONARY EOSINOPHILIA;

EID: 78549288544     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-11-160     Document Type: Article

References (54)

1. Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance--United States, 1971-2000. MMWR Surveill Summ 2002, 51(6):1-16.
2. National Heart LaBI Morbidity and Mortality: 2007 Chart Book On Cardiovascular, Lung and Blood Diseases. 2007, National Heart LaBI.
3. Rosenstreich DL, Eggleston P, Kattan M, Baker D, Slavin RG, Gergen P, Mitchell H, McNiff-Mortimer K, Lynn H, Ownby D, et al. The role of cockroach allergy and exposure to cockroach allergen in causing morbidity among inner-city children with asthma. N Engl J Med 1997, 336(19):1356-1363. 10.1056/NEJM199705083361904, 9134876.
4. Campbell EM, Kunkel SL, Strieter RM, Lukacs NW. Temporal role of chemokines in a murine model of cockroach allergen-induced airway hyperreactivity and eosinophilia. J Immunol 1998, 161(12):7047-7053.
5. McKinley L, Kim J, Bolgos GL, Siddiqui J, Remick DG. Reproducibility of a novel model of murine asthma-like pulmonary inflammation. Clin Exp Immunol 2004, 136(2):224-231. 10.1111/j.1365-2249.2004.02461.x, 15086384.
6. National Heart La BI Guidelines for the diagnosis and management of asthma. 2007, National Heart La BI.
7. Barnes PJ. Inhaled glucocorticoids for asthma. N Engl J Med 1995, 332(13):868-875. 10.1056/NEJM199503303321307, 7870143.
8. Becker, et al. Immunotherapy: Rationale for allergen immunotherapy. Canadian Medical Association Journal 2005, s46-s50. 1329954, 16157737.
9. Golden DB, Kagey-Sobotka A, Norman PS, Hamilton RG, Lichtenstein LM. Outcomes of allergy to insect stings in children, with and without venom immunotherapy. N Engl J Med 2004, 351(7):668-674. 10.1056/NEJMoa022952, 15306668.
10. Frew AJ. Sublingual immunotherapy. N Engl J Med 2008, 358(21):2259-2264. 10.1056/NEJMct0708337, 18499568.
11. Giampiero. Sublingual Desensitization: A new approach to the latex allergy problem. Anesthesia and Analgesia 2002, 60:956-960.
12. Gavett SH, OHearn DJ, Li X, Huang SK, Finkelman FD, Wills-Karp M. Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice. J Exp Med 1995, 182(5):1527-1536. 10.1084/jem.182.5.1527, 2192202, 7595222.
13. Kim J, McKinley L, Siddiqui J, Bolgos GL, Remick DG. Prevention and reversal of pulmonary inflammation and airway hyperresponsiveness by dexamethasone treatment in a murine model of asthma induced by house dust. Am J Physiol Lung Cell Mol Physiol 2004, 287(3):L503-509. 10.1152/ajplung.00433.2003, 15132954.
14. Mckinley L, Kim J, Bolgos GL, Siddiqui J, Remick DG. Reproducibility of a novel model of murine asthma-like pulmonary inflammation. Clinical and Experimental Immunology 2004, 136(2):224-231. 10.1111/j.1365-2249.2004.02461.x, 1809026, 15086384.
15. Nemzek JA, Siddiqui J, Remick DG. Development and optimization of cytokine ELISAs using commercial antibody pairs. J Immunol Methods 2001, 255(1-2):149-157. 10.1016/S0022-1759(01)00419-7, 11470295.
16. Bartlett NW, Walton RP, Edwards MR, Aniscenko J, Caramori G, Zhu J, Glanville N, Choy KJ, Jourdan P, Burnet J, et al. Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammation. Nature Medicine 2008, 14(2):199-204. 10.1038/nm1713, 18246079.
17. Hamelmann E, Schwarze J, Takeda K, Oshiba A, Larsen GL, Irvin CG, Gelfand EW. Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. American Journal of Respiratory and Critical Care Medicine 1997, 156(3):766-775.
18. Lomask M. Further exploration of the Penh parameter. Experimental and Toxicologic Pathology 2006, 57:13-20. 10.1016/j.etp.2006.02.014, 16638630.
19. Adler A, Cieslewicz G, Irvin CG. Unrestrained plethysmography is an unreliable measure of airway responsiveness in BALB/c and C57BL/6 mice. Journal of Applied Physiology 2004, 97(1):286-292. 10.1152/japplphysiol.00821.2003, 15033965.
20. Lundblad LKA, Irvin CG, Adler A, Bates JHT. A reevaluation of the validity of unrestrained plethysmography in mice. Journal of Applied Physiology 2002, 93(4):1198-1207.
21. Mitzner W. Why can't mice just learn to pant?. Journal of Applied Physiology 2008, 105(2):402-402. 10.1152/japplphysiol.90713.2008, 18535131.
22. de Hennezel L, Debarre S, Ramisse F, Delamanche S, Harf A, Alonso JM, Calvet JH. Plethysmography for the assessment of pneumococcal pneumonia and passive immunotherapy in a mouse model. Eur Respir J 2001, 17(1):94-99. 10.1183/09031936.01.17100940, 11307763.
23. Hemmila MR, Kim J, Sun JM, Cannon J, Arbabi S, Minter RM, Su GL, Remick DG, Wang SC. Gene therapy with lipopolysaccharide binding protein for gram-negative pneumonia: respiratory physiology. J Trauma 2006, 61(3):598-605. discussion 605-596, 10.1097/01.ta.0000233763.18853.5b, 16966994.
24. Mansell AL, Walders N, Wamboldt MZ, Carter R, Steele DW, Devin JA, Monica TH, Miller AL, Wamboldt FS. Effect of body mass index on response to methacholine bronchial provocation in healthy and asthmatic adolescents. Pediatr Pulmonol 2006, 41(5):434-440. 10.1002/ppul.20368, 16477656.
25. Baydur A, Wilkinson L, Mehdian R, Bains B, Milic-Emili J. Extrathoracic expiratory flow limitation in obesity and obstructive and restrictive disorders: effects of increasing negative expiratory pressure. Chest 2004, 125(1):98-105. 10.1378/chest.125.1.98, 14718427.
26. Hoshino Y, Ayuse T, Kurata S, Schneider H, Kirkness JP, Patil SP, Schwartz AR, Oi K. The compensatory responses to upper airway obstruction in normal subjects under propofol anesthesia. Respir Physiol Neurobiol 2009, 166(1):24-31. 10.1016/j.resp.2009.01.001, 2754397, 19444926.
27. Rudolf CD. Rudolf's Pediatrics. 2002, 277. McGraw Hill.
28. Tantucci C, Ellaffi M, Duguet A, Zelter M, Similowski T, Derenne JP, Milic-Emili J. Dynamic hyperinflation and flow limitation during methacholine-induced bronchoconstriction in asthma. Eur Respir J 1999, 14(2):295-301. 10.1183/09031936.99.142, 10515404.
29. Cascao R, Rosario HS, Fonseca JE. Neutrophils: warriors and commanders in immune mediated inflammatory diseases. Acta Reumatol Port 2009, 34(2B):313-326.
30. Szczepaniak W, Wolanczyk-Medrala A, Medrala W. Modern views on the role of neutrophil in the pathogenesis of bronchial asthma. Pol Merkur Lekarski 2003, 14(79):55-58.
31. Peters-Golden M. The alveolar macrophage: the forgotten cell in asthma. Am J Respir Cell Mol Biol 2004, 31(1):3-7. 10.1165/rcmb.f279, 15208096.
32. Afshar R, Medoff BD, Luster AD. Allergic asthma: a tale of many T cells. Clin Exp Allergy 2008, 38(12):1847-1857. 10.1111/j.1365-2222.2008.03119.x, 19037961.
33. Calvani M, Giorgio V, Miceli Sopo S. Specific oral tolerance induction for food. A systematic review. Eur Ann Allergy Clin Immunol 42(1):11-19.
34. Baraldo S, Lokar Oliani K, Turato G, Zuin R, Saetta M. The Role of Lymphocytes in the Pathogenesis of Asthma and COPD. Curr Med Chem 2007, 14(21):2250-2256. 10.2174/092986707781696573, 17896974.
35. Busse WW, Sedgwick JB. Eosinophils in asthma. Ann Allergy 1992, 68(3):286-290.
36. Conroy DM, Williams TJ. Eotaxin and the attraction of eosinophils to the asthmatic lung. Respir Res 2001, 2(3):150-156. 10.1186/rr52, 2002069, 11686879.
37. Fahy JV. Eosinophilic and neutrophilic inflammation in asthma: insights from clinical studies. Proc Am Thorac Soc 2009, 6(3):256-259. 10.1513/pats.200808-087RM, 19387026.
38. Nakagome K, Dohi M, Okunishi K, Komagata Y, Nagatani K, Tanaka R, Miyazaki J, Yamamoto K. In vivo IL-10 gene delivery suppresses airway eosinophilia and hyperreactivity by down-regulating APC functions and migration without impairing the antigen-specific systemic immune response in a mouse model of allergic airway inflammation. J Immunol 2005, 174(11):6955-6966.
39. van Scott MR, Justice JP, Bradfield JF, Enright E, Sigounas A, Sur S. IL-10 reduces Th2 cytokine production and eosinophilia but augments airway reactivity in allergic mice. Am J Physiol Lung Cell Mol Physiol 2000, 278(4):L667-674.
40. Shin JH, Kang JM, Kim SW, Cho JH, Park YJ. Effect of oral tolerance in a mouse model of allergic rhinitis. Otolaryngol Head Neck Surg 142(3):370-375. 10.1016/j.otohns.2009.11.025, 20172383.
41. Russo M, Nahori MA, Lefort J, Gomes E, de Castro Keller A, Rodriguez D, Ribeiro OG, Adriouch S, Gallois V, de Faria AM, et al. Suppression of asthma-like responses in different mouse strains by oral tolerance. Am J Respir Cell Mol Biol 2001, 24(5):518-526.
42. Park KS, Park MJ, Cho ML, Kwok SK, Ju JH, Ko HJ, Park SH, Kim HY. Type II collagen oral tolerance; mechanism and role in collagen-induced arthritis and rheumatoid arthritis. Mod Rheumatol 2009, 19(6):581-589. 10.1007/s10165-009-0210-0, 19697097.
43. Keller AC, Mucida D, Gomes E, Faquim-Mauro E, Faria AM, Rodriguez D, Russo M. Hierarchical suppression of asthma-like responses by mucosal tolerance. J Allergy Clin Immunol 2006, 117(2):283-290. 10.1016/j.jaci.2005.10.019, 16461128.
44. Mucida D, Kutchukhidze N, Erazo A, Russo M, Lafaille JJ, Curotto de Lafaille MA. Oral tolerance in the absence of naturally occurring Tregs. J Clin Invest 2005, 115(7):1923-1933. 10.1172/JCI24487, 1142115, 15937545.
45. Faria AM, Weiner HL. Oral tolerance. Immunol Rev 2005, 206:232-259. 10.1111/j.0105-2896.2005.00280.x, 16048553.
46. Bandeira-Melo C, Herbst A, Weller PF. Eotaxins. Contributing to the diversity of eosinophil recruitment and activation. Am J Respir Cell Mol Biol 2001, 24(6):653-657.
47. Rankin SM, Conroy DM, Williams TJ. Eotaxin and eosinophil recruitment: implications for human disease. Mol Med Today 2000, 6(1):20-27. 10.1016/S1357-4310(99)01635-4, 10637571.
48. Dubois GR, Bruijnzeel PL. IL-4-induced migration of eosinophils in allergic inflammation. Ann N Y Acad Sci 1994, 725:268-273. 10.1111/j.1749-6632.1994.tb39809.x, 8030998.
49. Kouro T, Takatsu K. IL-5- and eosinophil-mediated inflammation: from discovery to therapy. Int Immunol 2009, 21(12):1303-1309. 10.1093/intimm/dxp102, 19819937.
50. Pope SM, Brandt EB, Mishra A, Hogan SP, Zimmermann N, Matthaei KI, Foster PS, Rothenberg ME. IL-13 induces eosinophil recruitment into the lung by an IL-5- and eotaxin-dependent mechanism. J Allergy Clin Immunol 2001, 108(4):594-601. 10.1067/mai.2001.118600, 11590387.
51. Castilow EM, Meyerholz DK, Varga SM. IL-13 is required for eosinophil entry into the lung during respiratory syncytial virus vaccine-enhanced disease. J Immunol 2008, 180(4):2376-2384.
52. Akbari O, DeKruyff RH, Umetsu DT. Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat Immunol 2001, 2(8):725-731. 10.1038/90667, 11477409.
53. Battaglia M, Gianfrani C, Gregori S, Roncarolo MG. IL-10-producing T regulatory type 1 cells and oral tolerance. Ann N Y Acad Sci 2004, 1029:142-153. 10.1196/annals.1309.031, 15681753.
54. Safadi R, Alvarez CE, Ohta M, Brimnes J, Kraus T, Mehal W, Bromberg J, Mayer L, Friedman SL. Enhanced oral tolerance in transgenic mice with hepatocyte secretion of IL-10. J Immunol 2005, 175(6):3577-3583.